Search
Search Constraints
You searched for: Author/Creator Green, Freedom M.Limit your search
- Green, Freedom M. [remove] 3
- 615.372 3
- Vaccines -- Periodicals 3
- ACE2 angiotensin converting enzyme-2 -- AE adverse event -- COVID-19 coronavirus disease 2019 -- ELISA Enzyme Linked Immunosorbent Assay -- HCS human convalescent serum -- PBMC peripheral blood mononuclear cell -- PRNT Plaque Reduction Neutralization Test -- SAE serious adverse event -- SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 -- SP Spike Protein -- SP/RBD spike protein receptor binding domain -- VOICE Vaccination Against COVID-19 in Cancer clinical trial 1
- ACE2 angiotensin converting enzyme-2 -- AE adverse event -- ELISA Enzyme Linked Immunosorbent Assay -- HCS human convalescent serum -- SAE serious adverse event -- SP Spike Protein -- SP/RBD spike protein receptor binding domain 1
- ACE2 angiotensin converting enzyme-2 -- Ag antigen -- APCs antigen-presenting cells -- ELISA Enzyme Linked Immunosorbent Assay -- EUA Emergency Use Authorization -- HCS Human convalescent serum -- ID50 Inhibitory Dilution 50% -- MFI mean fluorescent intensity -- nAb neutralizing antibody -- NHP non-human primate -- OD optical density -- P passage -- PFU plaque-forming units -- PRNT plaque reduction neutralization test -- PRNT50 maximum dilution with greater than 50% inhibition -- SP Spike Protein -- SP/RBD spike protein receptor binding domain 1
- Infectious disease -- Coronavirus -- Prophylaxis -- Pandemic -- COVID-19 -- Fc-fusion 1
- Infectious disease -- Coronavirus -- Prophylaxis -- Pandemic -- COVID-19 -- Fc-fusion -- SARS-CoV-2 -- AKS-452 -- Vaccine 1
- Infectious disease -- Coronavirus -- Prophylaxis -- Pandemic -- COVID-19 -- Fc-fusion -- SARS-CoV-2 -- AKS-452 -- Vaccine -- Phase 2 1